In patients with end-stage renal disease, higher levels of proinflammatory cytokines such as tumor necrosis factor alpha (TNFα) and interleukin-6 (IL-6) have been consistently observed and are thought to contribute to ACD [37, 38]. This evidence concerns the gene TNF and stage 5 chronic kidney disease.